You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
American Association for Clinical Chemistry
Improving healthcare through laboratory medicine
Home
|
Customer Service
|
Site Map
|
Cart
|
Login
About AACC
Members
Events
Government & Public Affairs
Resource Centers
Professional Development
Publications
AACC Store
>
Members
>
NACB - The AACC Academy
>
NACB Blog
Recent Posts
Newborn Screening for Severe Combined Immunodeficiency (SCID): Should it be performed?
Are reference change values more useful than population-based reference intervals?
Autoimmune diabetes and related conditions
Where Is the Hemoglobin S?
Categories
Cancer and Tumor Markers
Case Study
Clinical Translational Science/Proteomics
CVD/Markers/Risk Factors
Diabetes/Endocrinology
Government Affairs/Patient Safety
Immunology/Infectious Disease
Instrumentation/Technology
Management/Medical Informatics
Molecular Pathology and Genetics
New/Other Disease Markers
Nutrition
POC Testing
Renal/GI/Hepatic
Special Populations
TDM/Toxicology
Archives
Year
: 2013
May 2013
April 2013
March 2013
February 2013
January 2013
Year
: 2012
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
Year
: 2011
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
RSS Feed
NACB Blog
Should Creatinine Standardization Change How Drug Doses Are Calculated?
6/28/2011 8:24 AM |
Comments (0)
Recommend (1,404)
By
Angela M. Ferguson, PhD
In 2006, the Laboratory Working Group of the National Kidney Disease Education Program (NKDEP) published recommendations to standardize serum creatinine measurements to improve the accuracy of the values reported by clinical laboratories (1). By the end of 2009, most laboratories were using method...(
Read More
)
Posted at 6/28/2011 8:24 AM | Tags:
Renal/GI/Hepatic
|
TDM/Toxicology
Personalized Medicine: Bring on the Disruption
6/21/2011 8:40 AM |
Comments (0)
Recommend (851)
By
Roland Valdes, Jr, PhD
In 2007, I was asked to chair the AACC’s Personalized Medicine Advisory Task Force. It was our job to advise the AACC on matters related to personalized medicine. The first thing we needed was a definition of “personalized medicine.” After substantial deliberations we agreed that personalized medi...(
Read More
)
Posted at 6/21/2011 8:40 AM | Tags:
Management/Medical Informatics
Drug Testing in Pain Management and Substance Abuse Recovery Programs
6/14/2011 8:32 AM |
Comments (3)
Recommend (933)
By
Roger L. Bertholf, PhD
In 1986, President Ronald Reagan issued Executive Order 12564, which mandated a drug-free federal workplace. The concept was not new. The Department of Defense had established a program for detecting and punishing drug use among military personnel nearly 20 years earlier, during the Nixon administr...(
Read More
)
Posted at 6/14/2011 8:32 AM | Tags:
TDM/Toxicology
What Is Causing Elevated Iron and TIBC Concentrations in This Patient With Anemia?
6/7/2011 8:28 AM |
Comments (0)
Recommend (949)
By
William Winter, MD
A middle-aged woman was under the care of her physician for anemia. The following laboratory results were obtained at a time when the patient was not acutely ill. Patient results Reference intervalsSerum iron 1400 ug/dL 42 -135 ug/dLTIBC ...(
Read More
)
Posted at 6/7/2011 8:28 AM | Tags:
Case Study
(Hidden) Admin Links
About AACC
|
Members
|
Government & Public Affairs
|
Resource Centers
|
Professional Development
|
Publications
Home
|
Customer Service
|
Site Map
|
AACC Store
|
Login
Contact Us
|
Privacy Policy and Legal Disclaimer
|
Join AACC
©2013 American Association for Clinical Chemistry
1850 K Street, NW Suite 625
Washington, DC 20006
Phone: (800) 892-1400 | Fax: (202) 887-5093